SCHEMBL741356

SCHEMBL741356

CC(C)(NC(=O)c1cc2c(NC(=O)c3cccs3)n[nH]c2s1)c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.43
MEN1 O00255 5/20 0.43
AURKA O14965 1/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
KDM4E B2RXH2 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
ABL1 P00519 4/20 0.41
BCR P11274 2/20 0.41
MAPT P10636 4/20 0.39
MAPK1 P28482 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 2/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL743308 0.92 AURKA (0.48) KMT2AMEN1AURKANPC1RAB9A
SCHEMBL741526 0.91 RAB9A (0.41) KMT2AMEN1AURKANPC1RAB9A
SCHEMBL741896 0.89 RAB9A (0.47) KMT2AMEN1AURKANPC1RAB9A
SCHEMBL741622 0.88 RAB9A (0.41) KMT2AMEN1AURKANPC1RAB9A
SCHEMBL738866 0.87 AURKA (0.53) AURKANPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL1779010 0.86 RXFP1 (0.48) KMT2AMEN1AURKANPC1RAB9A
SCHEMBL739810 0.84 APLNR (0.47) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL739893 0.84 RAB9A (0.48) KMT2AMEN1AURKANPC1RAB9A
SCHEMBL741231 0.82 USP36 (0.45) KMT2AAURKANPC1RAB9AABL1
SCHEMBL1778008 0.81 AURKA (0.49) AURKAABL1BCRTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed